Killing bacteria within biofilms by sustained release of tetracycline from triple-layered electrospun micro/nanofibre matrices of polycaprolactone and poly(ethylene-co-vinyl acetate)

被引:32
作者
Alhusein, Nour [1 ]
De Bank, Paul A. [1 ]
Blagbrough, Ian S. [1 ]
Bolhuis, Albert [1 ]
机构
[1] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
关键词
Biofilms; Drug delivery; Electrospinning; Multilayer; Nanofibre; Polycaprolactone; Poly(ethylene-co-vinyl acetate); Tetracycline; Wound dressing; WOUND DRESSINGS; SUSCEPTIBILITY; EFFICACY; STRAINS; ANTIBIOTICS; STRATEGIES;
D O I
10.1007/s13346-013-0164-9
中图分类号
TH7 [仪器、仪表];
学科分类号
0804 ; 080401 ; 081102 ;
摘要
We report the controlled release of the antibiotic tetracycline (tet) HCl from a triple-layered electrospun matrix consisting of a central layer of poly(ethylene-co-vinyl acetate (PEVA) sandwiched between outer layers of poly-epsilon-caprolactone (PCL). These micro/nanofibre layers with tet successfully encapsulated (essentially quantitatively at 3 and 5 % w/w) in each layer, efficiently inhibited the growth of a panel of bacteria, including clinical isolates, as shown by a modified Kirby-Bauer disc assay. Furthermore, they demonstrated high biological activity in increasingly complex models of biofilm formation (models that are moving closer to the situation in a wound) by stopping biofilm formation, by killing preformed biofilms and killing mature, dense biofilm colonies of Staphylococcus aureus MRSA252. Tet is clinically useful with potential applications in wound healing and especially in complicated skin and skin-structure infections; electrospinning provides good encapsulation efficiency of tet within PCL/PEVA/PCL polymers in micro/nanofibre layers which display sustained antibiotic release in formulations that are anti-biofilm.
引用
收藏
页码:531 / 541
页数:11
相关论文
共 40 条
  • [1] Electrospun matrices for localised controlled drug delivery: release of tetracycline hydrochloride from layers of polycaprolactone and poly(ethylene-co-vinyl acetate)
    Alhusein, Nour
    Blagbrough, Ian S.
    De Bank, Paul A.
    [J]. DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2012, 2 (06) : 477 - 488
  • [2] Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin
    Anderl, JN
    Franklin, MJ
    Stewart, PS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) : 1818 - 1824
  • [3] TESTING THE SUSCEPTIBILITY OF BACTERIA IN BIOFILMS TO ANTIBACTERIAL AGENTS
    ANWAR, H
    DASGUPTA, MK
    COSTERTON, JW
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (11) : 2043 - 2046
  • [4] Novel Clues on the Specific Association of Streptococcus gallolyticus subsp gallolyticus With Colorectal Cancer
    Boleij, Annemarie
    Muytjens, Carla M. J.
    Bukhari, Sarah I.
    Cayet, Nadege
    Glaser, Philippe
    Hermans, Peter W. M.
    Swinkels, Dorine W.
    Bolhuis, Albert
    Tjalsma, Harold
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (08) : 1101 - 1109
  • [5] RAPI, MODIFIED KIRBY-BAUER SUSCEPTIBILITY TEST WITH SINGLE, HIGH-CONCENTRATION ANTIMICROBIAL DISKS
    BOYLE, VJ
    FANCHER, ME
    ROSS, RW
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1973, 3 (03) : 418 - 424
  • [6] National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
    Cardo, D
    Horan, T
    Andrus, M
    Dembinski, M
    Edwards, J
    Peavy, G
    Tolson, J
    Wagner, D
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) : 470 - 485
  • [7] Burn wound infections
    Church, D
    Elsayed, S
    Reid, O
    Winston, B
    Lindsay, R
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2006, 19 (02) : 403 - +
  • [8] In vitro efficacy of bismuth thiols against biofilms formed by bacteria isolated from human chronic wounds
    Folsom, J. P.
    Baker, B.
    Stewart, P. S.
    [J]. JOURNAL OF APPLIED MICROBIOLOGY, 2011, 111 (04) : 989 - 996
  • [9] Survival strategies of infectious biofilms
    Fux, CA
    Costerton, JW
    Stewart, PS
    Stoodley, P
    [J]. TRENDS IN MICROBIOLOGY, 2005, 13 (01) : 34 - 40
  • [10] Fux Christoph A, 2003, Expert Rev Anti Infect Ther, V1, P667, DOI 10.1586/14787210.1.4.667